Catalyst
Slingshot members are tracking this event:
Allergan (AGN) Adds to Liver Disease Portfolio by Acquiring Privately Held Akarna Therapeutics for $50 MM Upfront + Potential Milestone Payments
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| AGN |
|
|
Akarna Therapeutics |
|
|
|
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 20, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Liver Disease Portfolio, Nash, Akn-083, Acquisition, Milestone Payments
